ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 179

CD11b+Gr1dimcells, Which Are Induced By GM-CSF Produced By Th17 and Group3 Innate Lymphoid Cell, May Facilitate the Progression of Pneumonitis in SKG Mice

Sho Sendo1, Jun Saegusa1, Takaichi Okano2, Soshi Takahashi3 and Akio Morinobu1, 1Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan, 2Rheumatology and Clinical immunology, Kobe University Graduate School of Medicine, Kobe, Japan, 3Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: animal models and rheumatoid arthritis, cytokines, Dendritic cells, Lung Disease, pathogenesis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Innate Immunity and Rheumatic Disease - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid lung disease is a prognostic factors of rheumatoid arthritis in human. The pathogenesis and the mechanism of rheumatoid lung disease is unclear. Zymosan A (ZyA)-treated SKG mice develop not only arthritis but also pneumonitis. To clarify the mechanism of rheumatoid lung disease in human, we analyzed the pneumonitis in SKG mice, which is similar to rheumatoid lung disease in human.

Methods: SKG mice were induced pneumonitis by ZyA injection. The severity of pneumonitis three months after ZyA injection was evaluated by the area of diffusely affected lesion in HE stain, as follows: histological score (HS) 0: affected area <10%, HS1: 10-29%, HS2: 30-59%, HS3: ≥60%. Lung-infiltrating cells (T cells, myeloid cells, innate lymphoid cells (ILCs)) were evaluated by flow cytometry. In vitro, lung-infiltrating cells were cultured with GM-CSF (and IL-4) for 5 days and evaluated by flow cytometry. CSFE-labeled naïve T cells were cultured with isolated CD11b+Gr1dimcells from lung, and stimulated with anti-CD3 and anti-CD28 monoclonal antibodies. After three days, Cell proliferation was examined by measuring CFSE fluorescence with flow cytometry.

Results: Histological analysis revealed that ZyA-treated mice developed various severity of pneumonitis; HS1: 30%, HS2: 50%, HS3: 20%. Unique cells with large and bright nucleus emerged only in the specimen of HS3. Flow cytometric analysis revealed that CD11b+Gr1+cells, CD11b+Gr1dimcells, Th17 cells, regulatory T cells (Treg), and ILC3s were increased, and the proportion of these cells varied depending on the HS: CD11b+Gr1+cells decreased as the progression of HS, while CD11b+ Gr1dimcells emerged only in the lung of HS3 (Figure1). Most of CD11b+ Gr1dimcells expressed CD11c, and the cells facilitated the naïve T cell proliferation in vitro. GM-CSF (and IL-4) induced the differentiation of CD11b+Gr1dimcells from total lung cells. The GM-CSF mRNA was significantly increased in the lung of ZyA-treated SKG mice compared to that of normal saline (NS)-treated SKG mice. Intracellular cytokine staining revealed that GM-CSF-producing Th17 and ILC3s were significantly increased in the lung of ZyA-treated SKG mice.

Conclusion: CD11b+Gr1dimcells, which are induced by GM-CSF produced by Th17 and ILC3s, may facilitate the progression of pneumonitis in SKG mice.


Disclosure: S. Sendo, None; J. Saegusa, None; T. Okano, None; S. Takahashi, None; A. Morinobu, None.

To cite this abstract in AMA style:

Sendo S, Saegusa J, Okano T, Takahashi S, Morinobu A. CD11b+Gr1dimcells, Which Are Induced By GM-CSF Produced By Th17 and Group3 Innate Lymphoid Cell, May Facilitate the Progression of Pneumonitis in SKG Mice [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/cd11bgr1dimcells-which-are-induced-by-gm-csf-produced-by-th17-and-group3-innate-lymphoid-cell-may-facilitate-the-progression-of-pneumonitis-in-skg-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cd11bgr1dimcells-which-are-induced-by-gm-csf-produced-by-th17-and-group3-innate-lymphoid-cell-may-facilitate-the-progression-of-pneumonitis-in-skg-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology